Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Wayne State University
mi
from
Detroit, MI
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Michigan State University, Sparrow Health System
mi
from
East Lansing, MI
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Michigan State University, Sparrow Health System
mi
from
East Lansing, MI
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
ST. Luke's Hospital
mi
from
Kansas City, MO
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
ST. Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Advance Neurology Specialists
mi
from
Great Falls, MT
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Advance Neurology Specialists
mi
from
Great Falls, MT
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
St. Francis Medical Center
mi
from
Trenton, NJ
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
St. Francis Medical Center
mi
from
Trenton, NJ
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
SUNY at Stony Brook, University Hospital at Stony Brook
mi
from
Stony Brook, NY
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
SUNY at Stony Brook, University Hospital at Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Moses Cone Hospital
mi
from
Greensboro, NC
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Moses Cone Hospital
mi
from
Greensboro, NC
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Clinical Research Center of Winston-Salem
mi
from
Winston-Salem, NC
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Clinical Research Center of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Summa Health System Neurology and Neuroscience Associates
mi
from
Akron, OH
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Summa Health System Neurology and Neuroscience Associates
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Chattanooga Neurology Associates
mi
from
Chattanooga, TN
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Chattanooga Neurology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Methodist University Hospital
mi
from
Memphis, TN
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Methodist University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
INOVA Research Center
mi
from
Falls Church, VA
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
INOVA Research Center
mi
from
Falls Church, VA
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Charleston Area Medical Center Health Education and Research Institute
mi
from
Charleston, WV
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Charleston Area Medical Center Health Education and Research Institute
mi
from
Charleston, WV
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated:  10/19/2015
General Hospital Middelheim, Dept. of Neurology
mi
from
Antwerp,
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI
Status: Enrolling
Updated: 10/19/2015
General Hospital Middelheim, Dept. of Neurology
mi
from
Antwerp,
Click here to add this to my saved trials
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Status: Enrolling
Updated:  10/19/2015
VA Medical Center, Omaha
mi
from
Omaha, NE
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Status: Enrolling
Updated: 10/19/2015
VA Medical Center, Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy
Vitamin E Treatment for LCHAD Associated Neuropathy
Status: Enrolling
Updated:  10/20/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy
Vitamin E Treatment for LCHAD Associated Neuropathy
Status: Enrolling
Updated: 10/20/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated:  10/20/2015
University of Cincinnati
mi
from
Cincinnati, OH
Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated: 10/20/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated:  10/20/2015
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated: 10/20/2015
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  10/20/2015
UCLA
mi
from
Los Angeles, CA
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 10/20/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  10/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 10/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  10/20/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 10/20/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  10/20/2015
University of Utah
mi
from
Salt Lake City, UT
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 10/20/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Intranasal Oxytocin in the Treatment of Autism
Intranasal Oxytocin in the Treatment of Autism
Status: Enrolling
Updated:  10/21/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Intranasal Oxytocin in the Treatment of Autism
Intranasal Oxytocin in the Treatment of Autism
Status: Enrolling
Updated: 10/21/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Tanner Center and Foundation for MS
mi
from
Birmingham, AL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Tanner Center and Foundation for MS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
The Neurology Center
mi
from
Oceanside, CA
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
The Neurology Center
mi
from
Oceanside, CA
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
McCare Center Neurology Services
mi
from
Orlando, FL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
McCare Center Neurology Services
mi
from
Orlando, FL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Neurology Center of Fairfax
mi
from
Fairfax, VA
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Neurology Center of Fairfax
mi
from
Fairfax, VA
Click here to add this to my saved trials
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated:  10/21/2015
UCLA
mi
from
Los Angeles, CA
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated: 10/21/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated:  10/21/2015
Seattle Children'S Research Institute
mi
from
Seattle, WA
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated: 10/21/2015
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated:  10/21/2015
Emory University
mi
from
Atlanta, GA
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Status: Enrolling
Updated: 10/21/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Randomized Double Blind Study Using Simvastatin for the PRevention Aof Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  10/22/2015
Univeristy of Illinois at Chicago, Dept of Neurosurgery
mi
from
Chicago, IL
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Randomized Double Blind Study Using Simvastatin for the PRevention Aof Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 10/22/2015
Univeristy of Illinois at Chicago, Dept of Neurosurgery
mi
from
Chicago, IL
Click here to add this to my saved trials
Does More Practice Improve Arm Movement After Stroke?
Dose Response of Movement Practice During Stroke Rehabilitation
Status: Enrolling
Updated:  10/23/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Does More Practice Improve Arm Movement After Stroke?
Dose Response of Movement Practice During Stroke Rehabilitation
Status: Enrolling
Updated: 10/23/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
Status: Enrolling
Updated:  10/23/2015
North Shore Long Island Jewish Health System
mi
from
Great Neck, NY
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
Status: Enrolling
Updated: 10/23/2015
North Shore Long Island Jewish Health System
mi
from
Great Neck, NY
Click here to add this to my saved trials
Impact of Impaired Cerebral Autoregulation on Postoperative Delirium in Elderly Patients Undergoing Spine Surgery
The Impact of Impaired Cerebral Autoregulation on the Development of Postoperative Delirium in Elderly Patients Undergoing Spine Surgery
Status: Enrolling
Updated:  10/23/2015
Johns Hopkins University
mi
from
Baltimore, MD
Impact of Impaired Cerebral Autoregulation on Postoperative Delirium in Elderly Patients Undergoing Spine Surgery
The Impact of Impaired Cerebral Autoregulation on the Development of Postoperative Delirium in Elderly Patients Undergoing Spine Surgery
Status: Enrolling
Updated: 10/23/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Phoenix, AZ
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Stanford, CA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Tampa, FL
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Atlanta, GA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Chicago, IL
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
St. Paul, MN
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Kansas City, MO
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Albany, NY
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Durham, NC
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials